IRADIMED CORP Insider Trading Activity
Every SEC Form 4 insider transaction reported for IRADIMED CORP (IRMD), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are IRMD insiders buying or selling?
In the last 12 months, IRADIMED CORP insiders reported 0 open-market purchases ($0) and 36 sales ($19.6M) — net selling of $19.6M. Since March 2018, Trabud has recorded 232 Form 4 filings for IRMD: 1 buys ($13.8K) and 231 sells ($94.0M).
Source: SEC EDGAR Form 4
What stands out
- No IRADIMED CORP insider made an open-market purchase in the last 12 months; the 36 reported open-market sales totaled $19.6M.
Key Statistics (March 2018 – Sep 8, 2026)
Total Form 4 filings
232
SEC EDGAR
Insider filers
12
Insider buys (1)
$13.8K
Insider sells (231)
$94.0M
Insider sentiment
Net sellingNet insider flow of $94.0M in net selling since March 2018, and $19.6M in net selling over the last 12 months.
Recent IRMD insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Monty K Allen | Director | Sale | 1.4K | $86.41 | $122.6K | SEC ↗ |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Director | Sale | 3.0K | $95.00 | $285.0K | SEC ↗ |
| Jun 2, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 2.5K | $90.60 | $226.5K | SEC ↗ |
| May 28, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $92.14 | $691.0K | SEC ↗ |
| May 20, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $87.64 | $657.3K | SEC ↗ |
| May 13, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $84.18 | $631.3K | SEC ↗ |
| May 6, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $85.71 | $642.9K | SEC ↗ |
| Apr 30, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $87.69 | $657.7K | SEC ↗ |
| Apr 22, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $92.55 | $694.1K | SEC ↗ |
| Apr 15, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $92.96 | $697.2K | SEC ↗ |
| Apr 7, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $95.63 | $717.2K | SEC ↗ |
| Apr 1, 2026 | Roger E. Susi | CEO, President, Chairman | Sale | 7.5K | $95.02 | $712.6K | SEC ↗ |
| Mar 25, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 7.5K | $100.35 | $752.6K | SEC ↗ |
| Mar 18, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 7.5K | $101.73 | $763.0K | SEC ↗ |
| Mar 10, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 7.5K | $100.06 | $750.5K | SEC ↗ |
| Mar 9, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 7.5K | $98.39 | $737.9K | SEC ↗ |
| Feb 13, 2026 | Monty K Allen | Director | Sale | 1.0K | $100.26 | $100.3K | SEC ↗ |
| Jan 27, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $100.65 | $503.3K | SEC ↗ |
| Jan 21, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $101.84 | $509.2K | SEC ↗ |
| Jan 13, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $97.45 | $487.2K | SEC ↗ |
| Jan 6, 2026 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $97.68 | $488.4K | SEC ↗ |
| Dec 30, 2025 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $97.66 | $488.3K | SEC ↗ |
| Dec 22, 2025 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $96.73 | $483.7K | SEC ↗ |
| Dec 17, 2025 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sale | 5.0K | $96.75 | $483.7K | SEC ↗ |
| Dec 12, 2025 | John Glenn | CHIEF FINANCIAL OFFICER | Sale | 15.0K | $97.29 | $1.5M | SEC ↗ |
Showing the 25 most recent of 232 Form 4 filings for IRADIMED CORP.
Most active IRMD insiders
- Roger E. Susi116 filings
- Brent Johnson62 filings
- Monty K Allen14 filings
- James B Hawkins11 filings
- Anthony Vuoto8 filings
Ask anything about IRMD insider activity
Use Trabud's AI agent to query IRADIMED CORP's Form 4 history in plain English — "Show me IRMD CEO purchases this year" or compare it against any other ticker.
Open the AI agentIRMD insider trading FAQ
Are IRADIMED CORP insiders buying or selling?
In the last 12 months, IRADIMED CORP insiders reported 0 open-market purchases ($0) and 36 sales ($19.6M) — net selling of $19.6M. Since March 2018, Trabud has recorded 232 Form 4 filings for IRMD: 1 buys ($13.8K) and 231 sells ($94.0M). Over the full record that is net selling of $94.0M.
How many insiders trade IRMD stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for IRADIMED CORP. The most recent filing was accepted on Sep 8, 2026.
Where does Trabud get IRMD insider trading data?
All IRMD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.